Founded in 1999, Conor MedSystems is a company that develops drug eluting stents to treat coronary artery disease. Their products include stents designed for drug delivery, with a delivery catheter that significantly improves process capability and throughput. The company is experienced in developing, running, and analyzing numerous DOEs, and has a working knowledge of GDP and GMP. They support product development by developing fixtures, processes, and manufacturing documentation, and have optimized processes through fixture design and implementation. The company also has experience working with and leading technical discussions with suppliers in the medical device industry.